
David Collier MD
Lupus & Related, Rheumatoid Arthritis & Related, Scleroderma & Related
Clinical Research Medical Director, Amgen, Inc.
Join to view full profile
742 Donnington CTSimi Valley, CA 93065
Phone+1 303-549-0249
Fax+1 805-791-3695
Dr. Collier is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UC San Francisco1980 - 1983
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1980
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
WashU MedicineClass of 1977
California Institute of TechnologyBS, Chemistry, 1969 - 1973
Certifications & Licensure
CO State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Listed in Best Doctors in America 2010
- Listed in 5280 Denver Mile-High Magazine physicians in Denver metropolitan area, 2008
- Fellow American College of Physicians, 2008
Publications & Presentations
PubMed
- Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi
Rheumatology and Therapy. 2024-06-01 - 7 citationsTreatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: resu...Dimitrios A Pappas, Jacqueline O'Brien, Lin Guo, Ying Shan, Joshua F Baker
Arthritis Research & Therapy. 2023-09-09 - 1 citationsFactors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.Jeffrey R Curtis, Paul Emery, Greg Kricorian, Priscilla K Yen, David H Collier
The Journal of Rheumatology. 2023-09-01
Journal Articles
- Anticardiolipin antibodies in scleroderma.Enzenauer RJ, Collier DH, Lopez LR, Journal of Clinical Rheumatology 12: 324-326
- Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon.Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsgar TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jim..., Arthritis Rheum 46(9):2410-2420
- Scleroderma-associated pulmonary hypertension: who’s at risk and why.Fagan KA, Collier DH, Badesch DB, Advances in Pulmonary Hypertension 1(2):5-9
Books/Book Chapters
Abstracts/Posters
- Clinical utility of serum hyaluronic acid levels in liver disease.Santos M, Kondo T, Wieczorek A, Collier D, Lopez L, Clinical Chemistry 41:S71
- Factors Associated with Relapse of Remission in Rheumatoid Arthritis.Harrold LR, Reed G, Collier DH, Park GS, Chang H, Koenig AS, Saunders KC, Zack DJ, Kremer JM, Greenberg JD, Arthritis Rheum 63:S122
- Health Literacy Predicts the Discrepancy Between Patient and Provider Global Assessments of Rheumatoid Arthritis Activity at a Public Urban Rheumatology Clinic.Hirsh JM, Boyle DJ, Collier DH, Oxenfeld A, Collier A, Cohen A, Caplan L, Arthritis Rheum 60:S369
Lectures
- Multivariate analysis of spinal and peripheral mineral loss in patients with rheumatoid arthritis.Pan-American Congress of Rheumatology, Washington, D. C
- Class II antigen MT3 association with rheumatoid arthritis.Eleventh ARA Western Regional Meeting, Monterey, California
- The association between collagen antibodies and human Ia molecules.Forty-Seventh Annual Scientific Meeting of the American Rheumatism Association, San Antonio, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









